Yayınlar & Eserler

Yayın Ağı
Makaleler 116
Tümü (116)
SCI-E, SSCI, AHCI (99)
SCI-E, SSCI, AHCI, ESCI (110)
ESCI (11)
Scopus (106)
TRDizin (45)
Diğer Yayınlar (1)

1. Clinical Characteristics and Survival Outcomes in Patients with Essential Thrombocythemia

Erdoğdu B., BAHTİYAR R. C., ÇINAR O. E., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.
Indian Journal of Hematology and Blood Transfusion , cilt.42, sa.4, ss.1244-1254, 2026 (SCI-Expanded, Scopus)

2. Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR)

GÜNDÜZ E., Ulas T., ÖZKALEMKAŞ F., TOPRAK S. K., Karakulak E. A., AR M. C., et al.
Annals of Hematology , cilt.105, sa.4, 2026 (SCI-Expanded, Scopus) Creative Commons License

3. Chronic Myeloid Leukemia Transforming into Acute Lymphoblastic Leukemia in a Patient with Gaucher Disease: A Case Report and Literature Review

Sayinalp Arslan B., ÇATAN ERDEKLİ F. T., Sağlam Ayhan A., ALADAĞ KARAKULAK E., MALKAN Ü. Y., BÜYÜKAŞIK Y.
Case Reports in Oncology , ss.437-443, 2026 (ESCI, Scopus)

4. Time-Dependent Differential Effects of SARS CoV 2 Spike Protein in Lung and Colon Epithelial Cell Lines

YILMAZ A., Yaka U., TÜRK S., MALKAN Ü. Y., GÖÇER S., HAZNEDAROĞLU İ. C., et al.
Jundishapur Journal of Microbiology , cilt.19, sa.1, 2026 (SCI-Expanded, Scopus)

5. Hepatic Metabolic Dysregulation as a Potential Amplifier of Leukemogenesis Following mRNA Vaccination: A Novel Mechanistic Hypothesis

Erdogdu B., KAPLAN O., ÇELEBİER M., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.
MEDICINA-LITHUANIA , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Anemia in the patients with acute myeloid leukemia revisited: Prognostic importance of anemia on treatment-naïve patients

Çınar O. E., Malkan U. Y., Aladag E., Demiroglu H., Büyükaşık Y., Göker H., et al.
Acta Medica , cilt.56, sa.2, ss.116-121, 2025 (TRDizin)

7. Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration

Erdogdu B., KAPLAN O., Fidan B. B., ÇELEBİER M., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.
CURRENT MOLECULAR MEDICINE , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Effects of Metabolic Parameters on The Clinical Course of Hematological Malignancies

Birsoy B., MALKAN Ü. Y.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.35, sa.1, ss.1-11, 2025 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

9. Periorbital edema and phototoxic rash associated with dasatinib: A case report

UĞURLU B. Ö., MALKAN Ü. Y.
SAGE OPEN MEDICAL CASE REPORTS , cilt.13, 2025 (ESCI, Scopus)

10. Differential proinflammatory responses of colon epithelial cells to SARS-CoV-2 spike protein and Pseudomonas aeruginosa lipopolysaccharide

YILMAZ A., Turk S., MALKAN Ü. Y., HAZNEDAROĞLU İ. C., Ucar G., ÖZGÜVEN Ş. V., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.49, ss.774-783, 2024 (SCI-Expanded, Scopus, TRDizin)

11. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience

Yiğit Kaya S., MUTLU Y. G., MALKAN Ü. Y., MEHTAP Ö., Keklik Karadağ F., Korkmaz G., et al.
Leukemia Research , cilt.140, 2024 (SCI-Expanded, Scopus)

12. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study

FIRAT O., KARA E., MALKAN Ü. Y., Demirkan K., İNKAYA A. Ç.
Thrombosis Research , cilt.236, ss.155-160, 2024 (SCI-Expanded, Scopus)

13. Pathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study)

Iseri Nepesov M., KILIÇ Ö., Sali E., Yesil E., Akar A., Kaman A., et al.
Children , cilt.11, sa.1, 2024 (SCI-Expanded, Scopus)

14. Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cells

TÜRK S., YILMAZ A., MALKAN Ü. Y., UÇAR G., TÜRK C.
TURKISH JOURNAL OF BIOLOGY , cilt.48, sa.1, 2024 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

15. The Potential Role of CAL2 and EZH2 Immunohistochemical Stainings as Diagnostic and Prognostic Surrogate Markers in Classical BCR/ABL1-negative Myeloproliferative Neoplasms

ÖZOĞUL E., Ozgeyik M. O., AYHAN E. A., MALKAN Ü. Y., HAZNEDAROĞLU İ. C., ÜNER A.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.33, sa.4, ss.248-257, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

16. The Relationship of Vitamin D Levels with Hematological Neoplasia

Topcu F. B., Ozdemir S., MALKAN Ü. Y.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.33, sa.4, ss.227-239, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

17. Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib

ILTAR U., SALİM O., Atas U., Vural E., Alhan F. N., YÜCEL O. K., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.33, sa.4, ss.191-197, 2023 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

18. Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?

REİS ARAS M., Afacan Öztürk H. B., yılmaz f., Güneş A. K., Malkan U. Y., ALBAYRAK M.
Hitit medical journal (Online) , cilt.5, sa.3, ss.170-174, 2023 (TRDizin)

19. Immunogenomic approach to the clinical management of COVID-19 syndrome

TÜRK S., HAZNEDAROĞLU İ. C., TÜRK C., malkan Ü. Y.
Eskisehir Medical Journal , cilt.4, ss.266-279, 2023 (Hakemli Dergi)

20. Pharmacobiology of topical Ankaferd hemostat in neoplastic disorders

Malkan U. Y., Haznedaroglu I. C.
The European Research Journal , cilt.9, sa.5, ss.1271-1276, 2023 (TRDizin) Creative Commons License

21. Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.

TÜRK S., Yanpar H., Baesmat A. S., Canli S., ÇINAR O. E., MALKAN Ü. Y., et al.
Heliyon , cilt.9, sa.9, 2023 (SCI-Expanded, Scopus)

22. Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study

GÖKER H., ÇINAR O. E., ISMAYILOV R., Özdemir E., MALKAN Ü. Y., ALADAĞ E., et al.
Acta Medica , cilt.54, sa.2, ss.97-102, 2023 (Hakemli Dergi) Creative Commons License

23. Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.

Malkan Ü. Y., Haznedaroglu I. C.
European review for medical and pharmacological sciences , cilt.27, sa.12, ss.5493-5506, 2023 (SCI-Expanded, Scopus)

24. Hypophosphatemia related to the use of ibrutinib

KARADENİZ M., ÇINAR O. E., Erdogdu B., MALKAN Ü. Y., GÖKER H., ÖZCEBE O. İ.
Journal of Oncology Pharmacy Practice , 2023 (SCI-Expanded, Scopus)

25. The Impact of JAK2 Mutation on Thrombosis in Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms

Arslan Kapuci A., Tiglioglu P., Hanci L. T., Saat H., MALKAN Ü. Y.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.2, ss.83-91, 2023 (SCI-Expanded, Scopus, TRDizin)

26. The Relationship Between GLIM Criteria and Recovery Times in the Leukemia Treatment Process

Yilmaz F., Aras M. R., Afacan Ozturk H. B., MALKAN Ü. Y., Kapuci A. A., Gunes A. K., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.3, ss.121-126, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

27. Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndrome

ŞENEL E., TÜRK S., MALKAN Ü. Y., Peker M. Ç., TÜRK C., GÜNER H. R., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.5, ss.1194-1204, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

28. A single-center experience of haploidentical stem cell transplantation in hematological malignancies

MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)

29. The Prognostic Significance of Prognostic Nutritional Index in Diffuse Large B Cell Lymphoma Patients

Aras M. R., Yilmaz F., Tiglioglu M., Saglam B., Yuzgenc B., Afacan Ozturk H. B., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.1, ss.8-13, 2023 (SCI-Expanded, Scopus, TRDizin)

30. The probiotic-induced dysregulation of immune-related genes in colon cells and relation with colorectal cancer

Türk S., Yılmaz A., Safari Baesmat A., Malkan Ü. Y., Ucar G., Türk C.
Cellular and Molecular Biology , cilt.69, sa.4, ss.37-45, 2023 (SCI-Expanded, Scopus) Creative Commons License

31. Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia After Hematopoietic Stem Cell Transplantation: A Cohort Study in a Tertiary Center Real-World Setting.

Göker H., Çınar O. E., Demiroğlu H., Malkan Ü. Y., Aladağ Karakulak E., Büyükaşık Y.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.40, ss.213-215, 2023 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

32. Harbinger of Trouble; Fingerprints in the Pre-Senile Stage of NK Cell’s Dysfunction

TÜRK S., Baesmat A. S., YILMAZ A., MALKAN Ü. Y., TÜRK C., HAZNEDAROĞLU İ. C., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.33, sa.2, ss.66-74, 2023 (SCI-Expanded, Scopus, TRDizin)

33. Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874

ÇINAR O. E., Erdogdu B., KARADENİZ M., ÜNAL S., MALKAN Ü. Y., GÖKER H., et al.
MEDICINA-LITHUANIA , cilt.58, sa.11, 2022 (SCI-Expanded, Scopus) Creative Commons License

34. NK-cell dysfunction of acute myeloid leukemia in relation to the renin-angiotensin system and neurotransmitter genes

TÜRK S., Baesmat A. S., YILMAZ A., TÜRK C., MALKAN Ü. Y., UÇAR G., et al.
OPEN MEDICINE , cilt.17, sa.1, ss.1495-1506, 2022 (SCI-Expanded, Scopus) Creative Commons License

35. Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

Çınar O. E., Göker H., Fidan K., Aydın Ö., Pashayev T., Malkan Ü. Y., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.39, sa.3, ss.152-159, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

36. Determination of etiology in patients admitted due to isolated leukopenia.

Mart G., Malkan Ü. Y., Buyukasik Y.
Medicine , cilt.101, sa.33, 2022 (SCI-Expanded, Scopus)

37. Antineoplastic Effects of Ankaferd Hemostat.

Malkan Ü. Y., Haznedaroglu I. C.
BioMed research international , cilt.2022, ss.2665903, 2022 (SCI-Expanded, Scopus) Creative Commons License

38. Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experience

Tiglioglu P., Albayrak M., Yildiz A., Tiglioglu M., Saglam B., Aras M. R., et al.
JOURNAL OF HEMATOPATHOLOGY , cilt.15, ss.83-93, 2022 (SCI-Expanded, Scopus)

39. Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute Thyroiditis

ŞENDUR S. N., ÖZMEN F., Oguz S. H., GÖNÜL İREMLİ B., MALKAN Ü. Y., Gurlek A., et al.
THYROID , cilt.32, sa.6, ss.640-647, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. A rare case of DIC in a patient with Wilson's disease: D-penicillamine

PARLAR Y. E., BALABAN H. Y., MALKAN Ü. Y., DENİZ E., UYSAL F. R.
HEPATOLOGY FORUM , cilt.3, sa.2, ss.61-63, 2022 (ESCI, Scopus, TRDizin)

41. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation

KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)

42. Hematological aspects of the COVID-19 syndrome

MALKAN Ü. Y., Haznedaroglu I. C.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.26, sa.12, ss.4463-4476, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

44. Improving Survival Besides the High Early Mortality Rate in Acute Promyelocytic Leukemia

Malkan Ü. Y., Koca E., BÜYÜKAŞIK Y.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.1-7, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

45. The Effect of CRAB Findings on the Prognosis of Multiple Myeloma Patients

Kalkisim A. F., Kalkisim H. K., MALKAN Ü. Y.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.32, sa.4, ss.191-201, 2022 (SCI-Expanded, Scopus, TRDizin)

46. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

47. Assessing the genetic impact of Enterococcus faecalis infection on gastric cell line MKN74

TÜRK S., Turk C., Temirci E. S., Malkan Ü. Y., UÇAR G., Ozguven S. V.
ANNALS OF MICROBIOLOGY , cilt.71, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case

Afacan Ozturk H. B., Albayrak M., Maral S., Reis Aras M., Yilmaz F., Akyol P., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.8, ss.2027-2029, 2021 (SCI-Expanded, Scopus)

49. A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION

Karadeniz M., Ucdal M. T., Goker H., Malkan Ü. Y.
Hematology, Transfusion and Cell Therapy , cilt.43, ss.1-3, 2021 (ESCI, Scopus)

50. Analysis of Demographic and Clinical Characteristics of Primary Myelofibrosis and Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Patients

Akyol P., Yıldız A., Albayrak M., Öztürk H. B. A., Maral S., Aras M. R., et al.
Gulhane Medical Journal , cilt.63, sa.2, ss.117-122, 2021 (Scopus, TRDizin)

51. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.1, ss.355-358, 2021 (SCI-Expanded, Scopus, TRDizin)

52. Interferon-Gene Family Alterations Following the SARS-Cov Infection in Association with Iron Metabolism and Lymphoid Biology

Malkan Ü. Y., TÜRK S., Turk C., Temirci E. S., Koker I., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.31, sa.2, ss.67-78, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

53. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosis

MALKAN Ü. Y., Albayrak M., Yildiz A., Maral S., Afacan Ozturk H. B., Comert P.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.1, ss.250-252, 2021 (SCI-Expanded, Scopus)

54. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.

Karataş A., Malkan Ü. Y., Velet M., Demiroğlu H., Büyükaşik Y., Telli Dizman G., et al.
Turkish journal of medical sciences , cilt.51, ss.1647-1652, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

55. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.
OPEN MEDICINE , cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded, Scopus) Creative Commons License

56. Current community transmission and future perspectives on the COVID-19 process

TÜRK S., Turk C., Malkan Ü. Y., Temirci E. S., Peker M. C., HAZNEDAROĞLU İ. C.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.3, ss.1001-1011, 2021 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

57. Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide

Turk S., Turk C., Akbar M., Kucukkaraduman B., Isbilen M., Demirkol C., et al.
PLOS ONE , cilt.15, sa.11, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

58. In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus

Turk C., TÜRK S., Temirci E. S., Malkan Ü. Y., HAZNEDAROĞLU İ. C.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.21, sa.2, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

59. Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factors

OKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.
LEUKEMIA & LYMPHOMA , cilt.61, ss.50-52, 2020 (SCI-Expanded, Scopus)

60. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)

Ciftciler R., Ciftciler A. E., Malkan Ü. Y., HAZNEDAROĞLU İ. C.
SAGE OPEN MEDICINE , cilt.8, 2020 (ESCI, Scopus)

61. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

OKAY M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.84-90, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

62. Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis

Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

63. Ankaferd Hemostat Affects Etoposide Resistance of the Malignant Melanoma Cells

Ghasemi M., OKAY M., Malkan Ü. Y., TÜRK S., Jabbar J., Hocaoglu H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.30, sa.1, ss.43-53, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

64. Three critical clinicobiological phases of the human SARS-associated coronavirus infections

Turk C., Turk S., Malkan Ü. Y., Haznedaroglu I. C.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.24, sa.16, ss.8606-8620, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. A Signet Ring Cell Carcinoma Presented as Refractory Acquired Thrombotic Thrombocytopenic Purpura

MALKAN Ü. Y., Albayrak M., Ozturk H. B., Aras M. R., Saglam B., Dogan K.
CASE REPORTS IN ONCOLOGY , cilt.13, sa.3, ss.1368-1372, 2020 (ESCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma

66. The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia

Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

67. Mantle cell lymphoma: a Turkish Multi-Center Study

OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.
JOURNAL OF BUON , cilt.24, sa.5, ss.2084-2089, 2019 (SCI-Expanded, Scopus)

68. The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemia

Ghasemi M., OKAY M., TÜRK S., Naeemaee R., Guver E., Malkan Ü. Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.20, sa.2, 2019 (SCI-Expanded, Scopus)

69. Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors

Gunes G., GÖKER H., DEMİROĞLU H., Malkan Ü. Y., BÜYÜKAŞIK Y.
BONE MARROW TRANSPLANTATION , cilt.54, sa.4, ss.595-600, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

70. The Impact of AT1R Inhibition via Losartan on the Anti-Leukemic Effects of Doxorubicin in Acute Myeloid Leukemia.

GHASEMİ m., OKAY M., TÜRK S., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., et al.
Journal Of The Renin-Angiotensin-Aldosterone System , 2019 (SCI-Expanded, Scopus)

71. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia

Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded, Scopus)

72. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

73. Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients

Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., Malkan Ü. Y., Saglam E. A., DEMİROĞLU H.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.12, sa.7, ss.9288-9294, 2019 (SCI-Expanded)

74. Fibrosis Development, Leukemic Transformation and Secondary Malignancies Complicating the Clinical Course of Essential Thrombocythemia

Ciftciler R., AKSU S., Malkan Ü. Y., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.29, sa.1, ss.14-21, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

75. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.4, ss.230-237, 2019 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

76. The factors affecting early death in newly diagnosed APL patients

Ciftciler R., HAZNEDAROĞLU İ. C., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE , cilt.14, sa.1, ss.647-652, 2019 (SCI-Expanded, Scopus) Creative Commons License

77. Indications and outcomes of splenectomy for hematological disorders

Ciftciler R., Pasayeva A., AKSU S., Ozcebe O., SAYINALP N., Malkan Ü. Y., et al.
OPEN MEDICINE , cilt.14, sa.1, ss.491-496, 2019 (SCI-Expanded, Scopus) Creative Commons License

78. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients

CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.
TRANSFUSION AND APHERESIS SCIENCE , cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)

79. Combination of novoseven and feiba in hemophiliac patients with inhibitors

Malkan Ü. Y., AKSU S.
OPEN MEDICINE , cilt.13, sa.1, ss.618-621, 2018 (SCI-Expanded, Scopus) Creative Commons License

80. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia

KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

81. The impact of chemo/immune therapy-related cytopenias on the clinical course of chronic lymphoid leukemia

Malkan Ü. Y., OKAY M., HAZNEDAROĞLU İ. C., GÜNEŞ G., Aslan N. A., ÖZCEBE O. İ., et al.
LEUKEMIA & LYMPHOMA , cilt.58, ss.96, 2017 (SCI-Expanded)

82. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis

Malkan Ü. Y., ÖZCEBE O. İ.
TRANSFUSION AND APHERESIS SCIENCE , cilt.56, sa.6, ss.880-882, 2017 (SCI-Expanded, Scopus)

83. Lipotoxicity-Related Hematological Disorders in Obesity

HAZNEDAROĞLU İ. C., MALKAN Ü. Y.
OBESITY AND LIPOTOXICITY , cilt.960, ss.469-487, 2017 (SCI-Expanded)

84. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission

AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

85. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines

TÜRK TÜRK S., Malkan Ü. Y., Ghasemi M., Hocaoglu H., Mutlu D., Gunes G., et al.
SAGE OPEN MEDICINE , cilt.5, 2017 (ESCI, Scopus)

86. Ankaferd hemostat induces DNA damage, apoptosis and cytotoxic activity by generating reactive oxygen species in melanoma and normal cell lines

KOÇYİĞİT A., GÜLER E. M., HAZNEDAROĞLU İ. C., Malkan Ü. Y.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.2, ss.2116-2126, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. A myelofibrosis case that develops mycobacterial infection after ruxolitinib treatment

Malkan Ü. Y., HAZNEDAROĞLU İ. C.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.10, sa.4, ss.7304-7307, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

88. Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis

Gunes H. N., Cokal B. G., Guler S. K., Yoldas T. K., Malkan Ü. Y., Demircan C. S., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.44, sa.6, ss.1454-1461, 2016 (SCI-Expanded, Scopus)

89. Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level

HURİ E., Dogantekin E., HAYRAN M., MALKAN Ü. Y., Ergun M., FIRAT A., et al.
SPRINGERPLUS , cilt.5, 2016 (SCI-Expanded, Scopus)

90. Local bone marrow renin-angiotensin system in the genesis of leukemia and other malignancies

Haznedaroglu I. C., Malkan Ü. Y.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , cilt.20, sa.19, ss.4089-4111, 2016 (SCI-Expanded, Scopus)

91. Reply: Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

Malkan U. Y., GÜNEŞ G., ETGÜL S., Aslan T., Aydin S., HAZNEDAROĞLU İ. C.
ANNALS OF PHARMACOTHERAPY , cilt.50, sa.4, ss.336, 2016 (SCI-Expanded, Scopus)

92. Chimeric antigen receptor T cell treatment in hematologic malignancies

GÖKER H., Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y.
TRANSFUSION AND APHERESIS SCIENCE , cilt.54, sa.1, ss.35-40, 2016 (SCI-Expanded, Scopus)

93. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias

Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

94. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

95. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

96. A CML case with resistant pleural effusion with tyrosine kinase inhibitor treatment

Malkan Ü. Y., HAZNEDAROĞLU İ. C.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.7, ss.14884-14887, 2016 (SCI-Expanded, Scopus)

97. Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids

Koluman A., Akar N., Malkan U. Y., HAZNEDAROĞLU İ. C.
BIOMED RESEARCH INTERNATIONAL , cilt.2016, 2016 (SCI-Expanded, Scopus) Creative Commons License

98. Expression Profiles of the Individual Genes Corresponding to the Genes Generated by Cytotoxicity Experiments with Bortezomib in Multiple Myeloma

GHASEMİ m., ALPSOY S., TÜRK TÜRK S., MALKAN Ü. Y., ATAKAN Ş., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY , cilt.33, sa.4, ss.286-292, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

99. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

100. A Bing-Neel syndrome case

Malkan Ü. Y., HAZNEDAROĞLU İ. C.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.9, sa.11, ss.22660-22663, 2016 (SCI-Expanded, Scopus)

101. Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.9, ss.61-64, 2016 (ESCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma

102. Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers

Malkan Ü. Y., Gunes G., Corakci A.
SPRINGERPLUS , cilt.4, 2015 (SCI-Expanded)

103. Management of De Novo CML and Imatinib-Induced Acute Rhabdomyolysis With the Second-Generation TKI, Dasatinib

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., Aslan T., Balaban S., HAZNEDAROĞLU İ. C.
ANNALS OF PHARMACOTHERAPY , cilt.49, sa.6, ss.740-742, 2015 (SCI-Expanded, Scopus)

104. Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease

GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.
CASE REPORTS IN HEMATOLOGY , 2015 (ESCI) Creative Commons License

105. A T-cell prolymphocytic leukemia case with central nervous system involvement

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., YEŞİLIRMAK A., ÜNER A.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.8, ss.14207-14209, 2015 (SCI-Expanded, Scopus)

106. Clinicopathological associations of acquired erythroblastopenia

GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)

107. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma

108. Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H.
CASE REPORTS IN MEDICINE , 2015 (ESCI, Scopus) Creative Commons License

109. Common variable immune deficiency associated Hodgkin's lymphoma complicated with EBV-linked hemophagocytic lymphohistiocytosis: a case report

Malkan Ü. Y., GÜNEŞ G., Aslan T., ETGÜL S., Aydin S., BÜYÜKAŞIK Y.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.8, ss.14203-14206, 2015 (SCI-Expanded, Scopus)

110. Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., HAZNEDAROĞLU İ. C.
CASE REPORTS IN HEMATOLOGY , 2015 (ESCI) Creative Commons License

111. The factors affecting early death after the initial therapy of acute myeloid leukemia

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)

112. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA , cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus) Creative Commons License

113. Not all anti-T lymphocyte globulin preparations are suitable for use in aplastic anemia: significantly inferior results with jurkat cell-reactive anti-T lymphocyte globulin in clinical practice

Eylem E., Yahya B., Ozlen B., Umit M., Gursel G., Ayse I., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , cilt.8, sa.9, ss.16334-16339, 2015 (SCI-Expanded)

114. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management

GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

115. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission

Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)

116. Giant Hemophilic Pseudotumor of the Iliopsoas: Case Report

MALKAN Ü. Y., Gunes G., Eliacik E., ISIK A., AKSU S., ATİLLA B., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.24, sa.4, ss.286-288, 2014 (SCI-Expanded, Scopus, TRDizin) Creative Commons License
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 97

1. Clinical Validation of Innate Lymphoid Cell-Associated Gene Signatures in the TCGA Acute Myeloid Leukemia Cohort

TÜRK S., TOPRAK U., TÜRK C., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.
European Cooperation in Science and Technology (COST) COST Action CA24117 – “Innate Lymphoid Cells – the European Quest for Innovative Cancer Prognosis and Immunotherapy (ILCquest)” 1st Spring meeting, Belgrade, Sırbistan, 23 - 24 Mart 2026, (Özet Bildiri)

2. Remodeling of the Innate Lymphoid Cell Compartment in Acute Myeloid Leukemia Revealed by an ILC-Centered Single-Cell Transcriptomic Reanalysis

TÜRK C., TOPRAK U., TÜRK S., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.
European Cooperation in Science and Technology (COST) COST Action CA24117 – “Innate Lymphoid Cells – the European Quest for Innovative Cancer Prognosis and Immunotherapy (ILCquest)” 1st Spring meeting, Belgrade, Sırbistan, 23 - 24 Mart 2026, (Özet Bildiri)

3. Retrospective Analysis of Turkish AML Registry Database, on Behalf of AML Working Group of Turkish Society of Hematology

Karakus V., Sevindik O. G., Karatas A., Yenihayat E. M., Polat M. G., Celik S., et al.
cilt.140, ss.8946-8947, (Özet Bildiri)

4. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)

5. LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM

MALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192, (Özet Bildiri)

6. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri) Creative Commons License

7. Lenalidomide provide better progression free survival than thalidomide and bortezomib in the first relapse of multiple myeloma patients after autologous transplantation

Malkan Ü. Y., Buyukasik Y., Demiroglu H., Ciftciler R., Gunes G., Okay M., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

8. Descriptive analysis of myeloproliferative diseases and its complications

OKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)

9. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018, (Tam Metin Bildiri)

10. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİ

OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.
5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018, (Özet Bildiri)

11. Erken Evre Kronik Lenfositer Löseminin Nadir Görünümleri ve Bir Mide Kanseri Vakası Birlikteliği: 2 vaka sunumu.

AYDIN M. S., ÜNER A., OKAY M., MALKAN Ü. Y., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
43. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 05 Kasım 2017, cilt.1, ss.66, (Özet Bildiri) Sürdürülebilir Kalkınma

12. RARE PRESENTATIONS OF EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA AND A COINCIDENCE WITH GASTRIC CANCER: 2 CASES

AYDIN M. S., ÜNER A., malkan Ü. Y., OKAY M., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
LEUKEMIA RESEARCH, İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, ss.16, (Özet Bildiri) Sürdürülebilir Kalkınma

13. AN ANAPLASTIC THYROID CARCINOMA CASE PRESENTING WITH LEUCOERYTHROBLASTIC BLOOD PICTURE

Okay M., Malkan Ü. Y., Can E. S., Gunes G., Demiroglu H.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

14. COEXISTENCE OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA AND VITILIGO: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

15. METHOTREXATE-RITUXIMAB TREATMENT IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

16. ELTROMBOPAG INDUCED HEPATOTOXICITY: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

17. DIMETHYL SULFOXIDE-INDUCED TONIC-CLONIC SEIZURE DURING INFUSION OF AUTOLOGOUS STEM CELL

Maral S., Albayrak M., Sahin O., Yildiz A., Pala C., Malkan Ü. Y., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

18. IMPORTANCE OF SCREENING ACCESSORY SPLEEN IN REFRACTORY IMMUNE THROMBOCYTOPENIA

Sahin O., Albayrak M., Yildiz A., Maral S., Ozturk C. P., Ozturk H. A., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

19. AN UNMUTATED HYPEREOSINOPHILIC SYNDROME CASE THAT IS SUCCESFULLY TREATED WITH IMATINIB MESYLATE

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

20. SJOGREN SYNDROME RELATED IMMUNE THROMBOCYTOPENIC PURPURA: A CASE REPORT

Can E. S., Malkan Ü. Y., Albayrak M., Gunes G.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

21. A CASE OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL IMMUNOPHENOTYPE

Okay M., Malkan Ü. Y., Can E. S., Gunes G., Demiroglu H.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

22. BLEOMYCIN-INDUCED PULMONARY FIBROSIS: EXPERIENCE OF TWO CASES IN A SINGLE CENTRE

Maral S., Albayrak M., Yildiz A., Sahin O., Ozturk C., Malkan Ü. Y., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

23. THE CORRELATION BETWEEN THE JAK2 ALLELE BURDEN AND HEMATOLOGIC/ CLINICAL PARAMETERS OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA PATIENTS

Can E. S., Malkan Ü. Y., Okay M., Albayrak M., Gunes G.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

24. THE EFFECT OF DISEASE STATUS BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION ON OVERALL SURVIVAL IN MULTIPLE MYELOMA

Gunes G., Malkan Ü. Y., Can E. S., Yayar O., Okay M., Goker H.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

25. SYNCHRONOUS GRANULOCYTIC SARCOMA AND MYCOBACTERIUM TUBERCULOSIS DIAGNOSED IN AN AXILLARY LYMPH NODE

Malkan Ü. Y., Khurami F. A., Arslankoz S., Arikok A., Can E. S., Albayrak M., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

26. A CASE REPORT: IMATINIB-RELATED PSORIASIFORM DERMATITIS

Sahin O., Albayrak M., Yildiz A., Maral S., Gunes G., Ozturk C. P., et al.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

27. COMPARISON OF BORTEZOMIB AND LENALIDOMIDE BASED REGIMENS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTS

Malkan Ü. Y., Gunes G., Yayar O., Can E. S., Okay M., Goker H.
8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)

28. Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.

malkan Ü. Y., DEMİROĞLU H., AKSU S., HAZNEDAROĞLU İ. C., SAYINALP N.
XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Almanya, 08 Temmuz 2017 - 13 Ocak 2018, cilt.1, ss.402, (Özet Bildiri)

29. The Impact of Chemo/Immune Therapy-­‐Related Cytopeniason the Clinical Course of Chronic Lymphoid Leukemia

OKAY M., HAZNEDAROĞLU İ. C., malkan Ü. Y., GÜNEŞ G., aslan n., AKSU S., et al.
iwcll2017, New York, Amerika Birleşik Devletleri, 12 - 15 Mayıs 2017, (Özet Bildiri)

30. Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi

ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017, (Özet Bildiri)

31. Experience with Pegylated Interferon alpha-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Bahcecioglu A. B., Etgul S., Aslan T., Aydin M. S., Malkan Ü. Y., Okay M., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology, California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri)

32. A HYPERHEMOLYTIC SYNDROME CASE

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

33. ERDHEIM-CHESTER DISEASE: A CASE REPORT

Ciftciler R., Okay M., Malkan Ü. Y., Gunes G., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

34. A CATASTROPHIC SERONEGATIVE ANTIPHOSPHOLIPID SYNDROME CASE

Malkan Ü. Y., Gunes G., Okay M., Ciftciler R., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

35. DERMATOSIS CAUSED BY ENOXAPARIN TREATMENT: A CASE REPORT

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

36. A MYELOFIBROSIS CASE THAT DEVELOPS MYCOBACTERIUM INFECTION AFTER RUXOLITINIB TREATMENT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

37. AN OSLER WEBER RENDU SYNDROME CASE THAT WAS SUCCESSFULLY TREATED WITH BEVACIZUMAB

Malkan Ü. Y., Gunes G., Okay M., Aksu S., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

38. ATYPICAL CLINICAL PRESENTATION OF A HODGKIN LYMPHOMA CASE

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Saglam A., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

39. GASTRIC INVOLVEMENT AS CLINICAL PRESENTATION OF BURKITT LYMPHOMA: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

40. COEXISTENCE OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AND AUTOIMMUNE HEMOLYTIC ANEMIA: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Ciftciler R., Aksu S.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

41. IBRUTINIB TREATMENT IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Aksu S., Sayinalp N.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

42. THE COEXISTENCE OF ANGIOIMMUNOBLASTIC T CELL LYMPHOMA, CHRONIC MYELOMONOCYTIC LEUKEMIA AND EBV: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Demiroglu H.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

43. THE COEXISTENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CASTLEMAN SYNDROME: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I., Ozcebe O.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

44. ANCA POSITIVE VASCULITIS THAT WAS TRIGGERED AFTER BENDAMUSTINE-RITUXIMAB TREATMENT: A CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Haznedaroglu I., Sayinalp N.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

45. AN IGE MYELOMA CASE

Okay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

46. AN INV(16) POSITIVE ACUTE MYELOMONOCYTIC LEUKEMIA CASE WITH POOR PROGNOSIS

Malkan Ü. Y., Gunes G., Okay M., Ciftciler R., Aksu S.
7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)

47. Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

TÜRK S., GHASEMİ M., MALKAN Ü. Y., ERİKÇİ A., GÖKER H., SAYINALP N., et al.
41. FEBS Kongresi, Türkiye, 3 - 08 Eylül 2016, (Özet Bildiri)

48. Determination of chemoterapoetic drugsensitivity subgroups of acute leukemia

Türk S., Ghasemi M., malkan Ü. Y., ERİKÇİ A., GÖKER H., HAZNEDAROĞLU İ. C., et al.
The FEBS Journal, 3 - 08 Eylül 2016, (Özet Bildiri)

49. Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia

TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374, (Özet Bildiri)

50. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY

Cekdemir D., Ozdemirkiran F., Guvenc S., Eser A., Ozkocaman V., Sahin H. H., et al.
24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141, (Özet Bildiri)

51. A CASE OF GRANULOCYTIC SARCOMA PRESENTING WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

Gunes G., Malkan Ü. Y., Eliacik E., Yayar O., Aksu S., Haznedaroglu I.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

52. A CASE OF CASTLEMAN DISEASE MANIFESTED WITH A MASS ASSOCIATED WITH THE RIGHT ATRIUM

Gunes G., Malkan Ü. Y., Aksu S., Demiroglu H., Ozcebe O.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

53. TREATMENT OF PYODERMA GANGRENOSUM WITH THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., Yayar O., Aslan T., AKSU S., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

54. AN IGD MYELOMA CASE THAT IS RESISTANT TO CARFILZOMIB

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., HAZNEDAROĞLU İ. C., DEMİROĞLU H., GÖKER H.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

55. MIXED PHENOTYPE ACUTE LEUKEMIA PRESENTING WITH EXTREME THROMBOCYTOSIS

Gunes G., Malkan Ü. Y., Etgul S., Yayar O., Demiroglu H., Buyukasik Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

56. STERNAL INVOLVEMENT OF MULTIPLE MYELOMA AS AN INITIAL LESION: AN UNUSUAL LOCALIZATION

Gunes G., Malkan Ü. Y., Yayar O., Aslan T., Goker H., Aksu S.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

57. A WALDENSTROM MACROGLOBINEMIA CASE WITH CRANIAL INVOLVEMENT

Malkan Ü. Y., Gunes G., Etgul S., Sayinalp N., Aksu S., Haznedaroglu I. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

58. CLINICOPATHOLOGICAL ASSOCIATIONS OF ACQUIRED ERYTHROBLASTOPENIA

Gunes G., Malkan Ü. Y., Eliacik E., Yayar O., Etgul S., Aslan T., et al.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

59. COMMON VARIABLE IMMUNE DEFICIENCY-ASSOCIATED HODGKIN'S LYMPHOMA COMPLICATED WITH EBV-LINKED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A CASE REPORT

Malkan Ü. Y., Gunes G., Etgul S., Aksu S., Haznedaroglu I. C., Buyukasik Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

60. CAUSES AND SIGNIFICANCE OF HEMOPHAGOCYTOSIS IN BONE MARROW ASPIRATION IN A TERTIARY-CARE MEDICAL CENTER

Etgul S., Aslan T., Malkan Ü. Y., Gunes G., Aydin S., Ozmen F., et al.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

61. BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

62. A T-CELL PROLYMPHOCYTIC LEUKEMIA CASE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

Malkan Ü. Y., Gunes G., Eliacik E., Yayar O., Goker H., Demiroglu H.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

63. A COMPOSITE LYMPHOMA CASE

Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

64. A LATE-ONSET ACUTE GRAFT VERSUS HOST DISEASE CASE WHO IS RESISTANT TO BOTH TACROLIMUS AND CYCLOSPORINE

Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

65. SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DUE TO AUTOIMMUNE, HEMATOLOGIC, INFECTIOUS DISEASES IN ADULT PATIENTS

Etgul S., Aslan T., Gunes G., Malkan Ü. Y., AYDIN DİLSİZ S., Ozmen F., et al.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

66. COEXISTENCE OF MULTIPLE MYELOMA IN A PATIENT WITH MANTLE CELL LYMPHOMA

Gunes G., Malkan Ü. Y., Yayar O., Aslan T., Ozcebe O., Goker H.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

67. A CHRONIC MYELOID LEUKEMIA CASE WHO HAS DISCONTINUED IMATINIB TREATMENT

Malkan Ü. Y., GÜNEŞ G., Aslan T., Yayar O., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

68. AN ACUTE MYELOID LEUKEMIA PATIENT COMPLICATED WITH HYPERLEUKOCYTOSIS

Malkan Ü. Y., GÜNEŞ G., Yayar O., HAZNEDAROĞLU İ. C., AKSU S., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

69. THERAPY-RELATED MYELODYSPLASTIC SYNDROME AFTER THE SUCCESSFUL TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

Malkan Ü. Y., GÜNEŞ G., Yayar O., AKSU S., DEMİROĞLU H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

70. THE COEXISTENCE OF B-THALASSEMIA MINOR AND SICKLE CELL ANEMIA: A CASE REPORT

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., DEMİROĞLU H., BÜYÜKAŞIK Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

71. A CASE OF B CELL LYMPHOMA: IN THE GRAY ZONE BETWEEN DIFFUSE LARGE B CELL LYMPHOMA AND CLASSICAL HODGKIN LYMPHOMA WITHOUT MEDIASTINAL DISEASE

Gunes G., Malkan Ü. Y., Etgul S., Yayar O., Aksu S., Buyukasik Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

72. A PLASMA CELL LEUKEMIA CASE

Malkan Ü. Y., GÜNEŞ G., ETGÜL S., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

73. ERDHEIM-CHESTER DISEASE: A RARE CAUSE OF RECURRENT FEVER OF UNKNOWN ORIGIN

Etgul S., Aydin S., Gunes G., Aslan T., Malkan Ü. Y., Aksu S., et al.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

74. THE FACTORS AFFECTING EARLY DEATH AFTER THE INITIAL THERAPY OF ACUTE MYELOID LEUKEMIA

Malkan Ü. Y., Gunes G., Eliacik E., Haznedaroglu I. C., Yayar O., Etgul S., et al.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

75. SUCCESSFUL TREATMENT OF RESISTANT CHRONIC GRAFT VERSUS HOST DISEASE WITH EXTRACORPOREAL PHOTOPHERESIS IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WHO HAS UNDERGONE ALLOGENEIC STEM CELL TRANSPLANTATION

Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., GÖKER H., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

76. A CASE OF COLD AGGLUTININ DISEASE ASSOCIATED WITH MALIGNANCY OF UNDETERMINED ORIGIN

Gunes G., Malkan Ü. Y., Etgul S., Sayinalp N., Aksu S.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

77. PRE-EMPTIVE USAGE OF RITUXIMAB IN A THROMBOTIC THROMBOCYTOPENIC PURPURA CASE

Yayar O., Malkan Ü. Y., Gunes G., Buyukasik Y.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

78. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.690, (Özet Bildiri)

79. THE EFFECT OF SERUM IRON TESTS AND IRON OVERLOAD ON TRANSPLANTATION-RELATED COMPLICATIONS AND PROGNOSIS IN ACUTE LEUKEMIA

Malkan Ü. Y., Gunes G., Demiroglu H., Goker H., Haznedaroglu I., Etgul S., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.658-659, (Özet Bildiri)

80. CHRONIC LYMPHOCYTIC LEUKEMIA MD ANDERSON CANCER CENTER PROGNOSTIC INDEX IS SUCCESSFUL BUT STILL CAN BE IMPROVED BY INCORPORATING SERUM LDH LEVEL

Gunes G., Buyukasik Y., Aslan N. A., Malkan Ü. Y., Haznedaroglu I. C., Demiroglu H., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.54-55, (Özet Bildiri)

81. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors

Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

82. Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

Koca E., Halacoglu A., Malkan Ü. Y., Arica D., Karakus S., GÖKER H., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

83. HODGKIN TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA

Gunes G., Malkan Ü. Y., Isik A., Eliacik E., Ozcebe O. I., Buyukasik Y., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

84. IS THE BURKITT LEUKEMIA PROGNOSIS AS GOOD AS EXPECTED?

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Balaban M. S., Aslan T., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

85. ASHERMAN SYNDROME WITH FACTOR 7 DEFICIENCY: CASE REPORT

Malkan Ü. Y., Gunes G., Eliacik E., Isik A., Sayinalp N., Ozcebe O. I., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

86. GIANT HEMOPHILIC PSEUDOTUMOR OF THE ILIOPSOAS: CASE REPORT

Malkan Ü. Y., Gunes G., Eliacik E., Aksu A. I. S., Atilla B., Buyukasik Y.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

87. TWO CASES WITH PRIMARY IMMUNE DEFICIENCY AND NEOPLASTIC LYMPHOID PROLIFERATION

Malkan Ü. Y., Gunes G., Eliacik E., Isik A., Sayinalp N., Aksu S., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

88. COEXISTENCE OF FACTOR X DEFICIENCY AND PROTHROMBOTIC MTHFR HOMOZYGOTE MUTATION IN PREGNANCY: CASE REPORT

Malkan Ü. Y., Gunes G., Eliacik E., Isik A., Sayinalp N., Haznedaroglu I. C., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

89. REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE DEVELOPING IN POST-TRANSPLANT FIFTH YEAR

Gunes G., Malkan Ü. Y., Isik A., Eliacik E., Demiroglu H., Ozcebe O. I., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

90. ADVANCED PHASE CHRONIC MYELOID LEUKEMIA RESISTANT TO IMATINIB, NILOTINIB, DASATINIB AND INTERFERON WITHOUT ABL KINASE MUTATION

Malkan Ü. Y., Gunes G., Eliacik E., Isik A., Sayinalp N., Aksu S.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

91. MYASTENIA GRAVIS AND WALDENSTROM MACROGLOBULINEMIA: IS COMMON IMMUNOLOGIC MECHANISM POSSIBLE?

Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Sayinalp N., Demiroglu H., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

92. IMATINIB-INDUCED ACUTE RHABDOMYOLYSIS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENT

Malkan Ü. Y., Gunes G., Eliacik E., Isik A., Sayinalp N., Goker H., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

93. DEVELOPMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA IN A PATIENT WITH JAK2V617F POSITIVE ESSENTIAL THROMBOCYTHEMIA

Ertop S., Aslaner M., Gunes G., Malkan Ü. Y., Tekin I.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

94. HYPEREOSINOPHILIC SYNDROME: CASE REPORT

Malkan Ü. Y., Gunes G., Okay M., Eliacik E., Isik A., Sayinalp N., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

95. TREATMENT OF CHRONIC MYELOID LEUKEMIA IN PREGNANCY

Gunes G., Malkan Ü. Y., Isik A., Eliacik E., Goker H., Haznedaroglu I. C., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

96. AN ESSENTIAL THROMBOCYTOSIS CASE, WHICH TRANSFORMED TO ACUTE MYELOID LEUKEMIA AFTER 12 YEARS

Malkan Ü. Y., Gunes G., Eliacik E., Isik A., Sayinalp N., Ozcebe O. I., et al.
5th International Eurasian Hematology Congress, Antalya, Türkiye, 15 - 19 Ekim 2014, cilt.38, (Özet Bildiri)

97. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML

AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014, (Tam Metin Bildiri)
Metrikler

Yayın

214

Yayın (WoS)

195

Yayın (Scopus)

108

Atıf (WoS)

398

H-İndeks (WoS)

11

Atıf (Scopus)

588

H-İndeks (Scopus)

13

Atıf (TrDizin)

9

H-İndeks (TrDizin)

2

Atıf (Sobiad)

1

H-İndeks (Sobiad)

1

Atıf (Diğer Toplam)

9

Toplam Atıf Sayısı

417

Proje

6

Tez Danışmanlığı

13

Açık Erişim

45
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER
SDG 17: AMAÇ 17: AMAÇLAR İÇİN ORTAKLIKLAR